AthemBio
PrivateLast Round
Grant
Aug 15, 2024
Total Funding Raised
$260,943
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AthemBio operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was an Accelerator round in August 2022.
AthemBio is a biotechnology company that develops automated, single-use bioprocessing platforms designed to reduce manufacturing complexity and costs for biologics and advanced therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AthemBio Comparables
Compare AthemBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sartorius Aktiengesellschaft | 76% | |
| Danaher | 73% | |
| Thermo Fisher Scientific Inc. | 73% |
For institutional investors. Book with your work email.
AthemBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2024 | ||||
| Accelerator | Aug 10, 2022 | ||||
| Grant | Feb 9, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AthemBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| First Flight Venture Center | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 5671% MoM, from 28 to 1.6K.
- Mar 1, 2026
Monthly visitors increased 494% MoM.
For institutional investors. Book with your work email.
AthemBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AthemBio's valuation, stock price, and market status.
Is AthemBio a public or private company?
AthemBio is a private company.
What is the current stock price of AthemBio?
AthemBio is a private company, so its shares have no public market price. Caplight tracks AthemBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AthemBio worth (valuation)?
Valuation information for AthemBio is not publicly available.
Can I buy AthemBio stock?
AthemBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AthemBio's last funding round?
AthemBio's most recent funding round was Grant on August 15, 2024.
Who are the main investors in AthemBio?
Key investors in AthemBio include National Science Foundation.
Will AthemBio IPO soon?
No public IPO plans have been announced for AthemBio.
How can I track AthemBio secondary market activity?
Caplight tracks bids, offers, and trades in AthemBio's shares on secondary markets.